Sue Friedman

1.5k total citations · 1 hit paper
29 papers, 616 citations indexed

About

Sue Friedman is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sue Friedman has authored 29 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sue Friedman's work include BRCA gene mutations in cancer (25 papers), Prenatal Screening and Diagnostics (6 papers) and Ethics in Clinical Research (4 papers). Sue Friedman is often cited by papers focused on BRCA gene mutations in cancer (25 papers), Prenatal Screening and Diagnostics (6 papers) and Ethics in Clinical Research (4 papers). Sue Friedman collaborates with scholars based in United States, United Kingdom and Canada. Sue Friedman's co-authors include Susan T. Vadaparampil, Leigha Senter, Dawn C. Allain, Gwendolyn P. Quinn, Cheryl A. Miree, Rebecca Sutphen, Lindsey King, Joanne Armstrong, Laura L. Holman and Michele Toscano and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Fertility and Sterility.

In The Last Decade

Sue Friedman

28 papers receiving 603 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

2024 67 citations Sue Friedman et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sue Friedman United States	14	453	169	134	127	120	29	616
Christine Lasset France	12	436 1.0×	107 0.6×	97 0.7×	81 0.6×	129 1.1×	29	572
Belinda Rahman Australia	13	434 1.0×	115 0.7×	128 1.0×	52 0.4×	158 1.3×	27	633
Lesley Andrews Australia	15	326 0.7×	68 0.4×	83 0.6×	80 0.6×	152 1.3×	45	562
Rochelle Demsky Canada	13	458 1.0×	60 0.4×	126 0.9×	246 1.9×	231 1.9×	25	686
Shelley R. McCormick United States	9	361 0.8×	125 0.7×	99 0.7×	33 0.3×	125 1.0×	16	518
John Malick United States	11	333 0.7×	105 0.6×	73 0.5×	56 0.4×	136 1.1×	12	627
Andrea Forman United States	17	543 1.2×	161 1.0×	172 1.3×	29 0.2×	142 1.2×	28	732
Cecelia Bellcross United States	12	496 1.1×	97 0.6×	112 0.8×	45 0.4×	195 1.6×	41	692
Irmgard Nippert Germany	14	381 0.8×	158 0.9×	128 1.0×	38 0.3×	58 0.5×	44	592
Devon Bonner United States	7	376 0.8×	72 0.4×	76 0.6×	33 0.3×	147 1.2×	15	451

Countries citing papers authored by Sue Friedman

Since Specialization

Citations

This map shows the geographic impact of Sue Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Friedman more than expected).

Fields of papers citing papers by Sue Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Friedman. The network helps show where Sue Friedman may publish in the future.

Co-authorship network of co-authors of Sue Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Friedman. A scholar is included among the top collaborators of Sue Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Friedman. Sue Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friedman, Sue, et al.. (2024). Identifying and addressing the needs of caregivers of patients with cancer: evidence on interventions and the role of patient advocacy groups. Future Oncology. 20(33). 2589–2602. 2 indexed citations

Chen, Lee-may, Mindy Goldman, Julie Mak, et al.. (2023). Changes in Bone Density in Carriers of BRCA1 and BRCA2 Pathogenic Variants After Salpingo-Oophorectomy. Obstetrics and Gynecology. 142(1). 160–169.

Friedman, Sue, et al.. (2022). An evidence‐based practice guideline of the National Society of Genetic Counselors for telehealth genetic counseling. Journal of Genetic Counseling. 32(1). 4–17. 13 indexed citations

Armstrong, Joanne, Kristian Lynch, Katherine S. Virgo, et al.. (2021). Utilization, Timing, and Outcomes of BRCA Genetic Testing Among Women With Newly Diagnosed Breast Cancer From a National Commercially Insured Population: The ABOARD Study. JCO Oncology Practice. 17(2). e226–e235. 16 indexed citations

Metcalfe, Kelly, Melanie A. Price, Carol Mansfield, et al.. (2020). Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis. British Journal of Cancer. 123(2). 268–274. 21 indexed citations

Mansfield, Carol, Kelly Metcalfe, Carrie Snyder, et al.. (2020). Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation. Hereditary Cancer in Clinical Practice. 18(1). 20–20. 5 indexed citations

DeRosa, Branlyn Werba, Alexandra K. Zaleta, Kelly Clark, et al.. (2020). Experience of financial burden and distress among people with ovarian cancer.. Journal of Clinical Oncology. 38(15_suppl). e19400–e19400. 1 indexed citations

Friedman, Sue, Ronit I. Yarden, E. Kuhn, et al.. (2020). Using consistent terms in precision medicine to eliminate patient confusion.. Journal of Clinical Oncology. 38(15_suppl). e24164–e24164. 4 indexed citations

O’Neill, Suzanne C., Rebekah Hamilton, Beth N. Peshkin, et al.. (2017). Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population. Familial Cancer. 17(3). 351–360. 16 indexed citations

10.

Liede, Alexander, Carol Mansfield, Kelly Metcalfe, et al.. (2017). Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Research and Treatment. 165(2). 433–444. 25 indexed citations

11.

Holman, Laura L., et al.. (2017). Decision-making surrounding genetic testing among women with ovarian carcinoma. Gynecologic Oncology. 145. 42–42. 2 indexed citations

12.

Armstrong, Joanne, Michele Toscano, Sue Friedman, et al.. (2016). Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population. Obstetrical & Gynecological Survey. 71(5). 287–288. 2 indexed citations

13.

Holman, Laura L., Sue Friedman, Molly S. Daniels, Charlotte C. Sun, & Karen H. Lu. (2014). Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecologic Oncology. 133(2). 283–286. 55 indexed citations

14.

Armstrong, Joanne, Michele Toscano, Sue Friedman, et al.. (2014). American BRCA Outcomes and Utilization of Testing (ABOUT) Study: A Pragmatic Research Model that Incorporates Personalized Medicine/Patient‐Centered Outcomes in a Real World Setting. Journal of Genetic Counseling. 24(1). 18–28. 8 indexed citations

15.

Pal, Tuya, Susan T. Vadaparampil, Jongphil Kim, et al.. (2013). Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers. Familial Cancer. 12(4). 615–619. 3 indexed citations

16.

Holman, Laura L., Sue Friedman, Molly S. Daniels, Charlotte C. Sun, & K.H. Lu. (2013). Acceptability of salpingectomy alone as risk-reducing surgery for BRCA mutation carriers. Gynecologic Oncology. 130(1). e104–e104. 2 indexed citations

17.

Friedman, Sue. (2012). Confronting Hereditary Breast and Ovarian Cancer. Johns Hopkins University Press eBooks. 7 indexed citations

18.

Sutphen, Rebecca, Heather M. Shappell, Susan T. Vadaparampil, et al.. (2010). Real world experience with cancer genetic counseling via telephone. Familial Cancer. 9(4). 681–689. 34 indexed citations

19.

Quinn, Gwendolyn P., Susan T. Vadaparampil, Lindsey King, Cheryl A. Miree, & Sue Friedman. (2009). Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer. Familial Cancer. 8(4). 441–449. 30 indexed citations

20.

Quinn, Gwendolyn P., Susan T. Vadaparampil, Crystal Wilson, et al.. (2008). Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertility and Sterility. 91(6). 2361–2368. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact